Your account is not claimed yet. You can sign up with ORCID to claim your account.

Laurent Désaubry (Laurent Desaubry)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Venues

Pathogens (Basel, Switzerland)

Blood

International journal of molecular sciences

The Journal of organic chemistry

Tianjin University of Science and Technology

Université de Strasbourg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tianjin University of Science and Technology

China

Adjunct professor :: the Sino-French Joint Lab of Nutrition and Medicinal Chemistry

Education History

Université de Strasbourg - Dec 11o 1992

France

PHD

Publications

Sara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, Antonio Cigliano, Giovanni Mario Pes, Maria M Simile, Laurent Désaubry, Jose J G Marin, Matthias Evert, Diego F Calvisi
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma. International journal of molecular sciences 24 (3) (2023)
Karen A Conrad, Hyunjeong Kim, Mohammad Qasim, Amel Djehal, Aaron D Hernday, Laurent Désaubry, Jason M Rauceo
Triazine-Based Small Molecules: A Potential New Class of Compounds in the Antifungal Toolbox. Pathogens (Basel, Switzerland) 12 (1) (2023)
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez-Hernandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Denisse Cortez Clemente, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood (2023)
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez-Hernandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Denisse Cortez Clemente, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood (2023)
Karen A Conrad, Hyunjeong Kim, Mohammad Qasim, Amel Djehal, Aaron D Hernday, Laurent Désaubry, Jason M Rauceo
Triazine-Based Small Molecules: A Potential New Class of Compounds in the Antifungal Toolbox. Pathogens (Basel, Switzerland) 12 (1) (2023)
Karen A Conrad, Hyunjeong Kim, Mohammad Qasim, Amel Djehal, Aaron D Hernday, Laurent Désaubry, Jason M Rauceo
Triazine-Based Small Molecules: A Potential New Class of Compounds in the Antifungal Toolbox. Pathogens (Basel, Switzerland) 12 (1) (2023)
Sara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, Antonio Cigliano, Giovanni Mario Pes, Maria M Simile, Laurent Désaubry, Jose J G Marin, Matthias Evert, Diego F Calvisi
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma. International journal of molecular sciences 24 (3) (2023)
Ahmad Najem, Mohammad Krayem, Serena Sabbah, Matilde Pesetti, Fabrice Journe, Ahmad Awada, Laurent Désaubry, Ghanem E Ghanem
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies. Cells 12 (14) (2023)
Sara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, Antonio Cigliano, Giovanni Mario Pes, Maria M Simile, Laurent Désaubry, Jose J G Marin, Matthias Evert, Diego F Calvisi
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma. International journal of molecular sciences 24 (3) (2023)
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez-Hernandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Denisse Cortez Clemente, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood (2023)
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez-Hernandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Denisse Cortez Clemente, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood (2023)
Karen A Conrad, Hyunjeong Kim, Mohammad Qasim, Amel Djehal, Aaron D Hernday, Laurent Désaubry, Jason M Rauceo
Triazine-Based Small Molecules: A Potential New Class of Compounds in the Antifungal Toolbox. Pathogens (Basel, Switzerland) 12 (1) (2023)
Wei Yang, Bo Mu, Jing You, Chenyu Tian, Huachao Bin, Zhiqiang Xu, Liting Zhang, Ronggang Ma, Ming Wu, Guo Zhang, Chong Huang, Linli Li, Zhenhua Shao, Lunzhi Dai, Laurent Désaubry, Sheng-Yong Yang
Non-classical ferroptosis inhibition by a small molecule targeting PHB2. Nature communications 13 (1) (2022)
Dong Wang, Redouane Tabti, Sabria Elderwish, Hussein Abou-Hamdan, Amel Djehal, Peng Yu, Hajime Yurugi, Krishnaraj Rajalingam, Canan G Nebigil, Laurent Désaubry
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases. Cellular and molecular life sciences : CMLS 77 (18) (2020)
Dakota N Jackson, Kibrom M Alula, Yaritza Delgado-Deida, Redouane Tabti, Kevin Turner, Xuan Wang, K Venuprasad, Rhonda F Souza, Laurent Désaubry, Arianne L Theiss
The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling. Cancer research 80 (17) (2020)
Carolin Ploeger, Thorben Huth, Raisatun Nisa Sugiyanto, Stefan Pusch, Benjamin Goeppert, Stephan Singer, Redouane Tabti, Ingrid Hausser, Peter Schirmacher, Laurent Désaubry, Stephanie Roessler
Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria. Cell death & disease 11 (11) (2020)
Dong Wang, Yuanyang Jiang, Linru Dong, Gaoyu Li, Baoying Sun, Laurent Désaubry, Peng Yu
One-Pot Selective Saturation and Functionalization of Heteroaromatics Leading to Dihydropyridines and Dihydroquinolines. The Journal of organic chemistry 85 (7) (2020)
Dong Wang, Yu Fan, Peng Yu, Laurent Désaubry
Recent advances in the synthesis of 2,3-dihydropyrroles. Chemical communications (Cambridge, England) 56 (42) (2020)
Xin Jin, Jianling Xie, Michael Zabolocki, Xuemin Wang, Tao Jiang, Dong Wang, Laurent Désaubry, Cedric Bardy, Christopher G Proud
The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis. The Journal of biological chemistry 295 (29) (2020)
Hussein Abou-Hamdan, Laurent Désaubry
Scalable 9-Step Synthesis of the Splicing Modulator NVS-SM2. The Journal of organic chemistry 83 (5) (2018)

Laurent Désaubry.css-eqlu8i{font-size:small;padding-left:4px;} (Laurent Desaubry)

Publication Activity (10 Years)

Top Topics

Top Venues

Laurent Désaubry (Laurent Desaubry)